Search results
11 wrz 2024 · Since the announcement in April 2024 that it had agreed with the Department of Health and Human Services' (HHS) earlier recommendation to reschedule cannabis, the DEA opened a 60-day public...
28 maj 2024 · In the 2018 Farm Bill, cannabis plants with less than .3% concentration of the major psychoactive component of marijuana, delta-9-tetrahydrocannabinol (THC), were removed from the CSA and legally defined as hemp.
With rescheduling, we can move faster to study the therapeutic benefits of cannabinoids. We can also breed plants with consistent combinations of cannabinoids or other metabolites that will be the source of effective medicines. President Biden called for the HHS and DEA to consider rescheduling of Cannabis in 2022.
8 wrz 2023 · The UN's decision to reschedule cannabis has ignited a passionate and complex debate. Here are three key points to understand the controversy: Medical Breakthroughs vs. Commercialization Concerns: Proponents argue that rescheduling cannabis will facilitate research and innovation, potentially leading to groundbreaking medical discoveries.
3 cze 2024 · The proposed rule to reschedule cannabis to a Schedule III drug represents a landmark change with far-reaching implications for the cannabis industry, patients, and consumers alike.
20 maj 2024 · The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for ...
16 paź 2024 · The Drug Enforcement Administration’s proposal to move cannabis to Schedule III should be finalized in early 2025, assuming there are no election-related setbacks in November. After it’s rescheduled, the Food and Drug Administration (FDA) can start approving cannabis-based drugs for sale at regular pharmacies, which unlocks a $2 trillion ...
